sprite-preloader
Dienstag, 28.02.2017 Börsentäglich über 12.000 News von 555 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoEMA's CHMP recommends approval of Novartis' Tafinlar in combination with Mekinist
MoOxford BioMedica's TroVax phase I/II trial yields encouraging results
MoAstraZeneca gets positive CHMP recommendation for hyperkalaemia drug
MoMerck's trial of inactivated varicella zoster virus vaccine meets primary end point
FrCyclacel's leukemia drug for elderly patients fails in phase 3 trial
FrProMetic's pulmonary fibrosis drug yields positive results in phase 2 trial
FrIncyte partners with University of Pennsylvania on cancer immunotherapy research
FrGSK, Innoviva's Relvar Ellipta shows positive effect in non-inferiority lung function study
DoImmusanT's phase 1b trial of celiac disease vaccine finds phase 2 dose regimen
DoPMV Pharma raises $74m for cancer drugs targeting p53
DoIDMC recommends to halt Argos' cancer vaccine candidate trial
MiFDA grants priority review to Pfizer's antibody-drug conjugate for ALL
MihVIVO says US body begins trial on malaria and Zika vaccine
MiAbzena signs antibody manufacturing development deal with University College London
MiEuropean Commission conditionally approves Roche's cancer drug Alecensa
21.02.Chi-Med starts phase II study of savolitinib in pulmonary sarcomatoid carcinoma
21.02.Modus Therapeutics raises £2.9m to support further development of sevuparin for SCD
21.02.Faron doses first patent in Traumakin's multi-organ failure study
20.02.Arix Bioscience raises £100m in IPO
20.02.Momenta announces FDA warning letter to contracted Glatopa's fill/finish manufacturer
20.02.Daiichi Sankyo, ArQule's tivantinib fails to meet primary end point in liver cancer study
20.02.AstraZeneca's Lynparza meets primary endpoint in breast cancer study
17.02.Valeant gets FDA approval for SILIQ to treat moderate-to-severe plaque psoriasis
17.02.Takeda acquires Ariad Pharmaceuticals
17.02.Pfizer's rheumatoid arthritis drug shows treatment benefit in combination but not alone